Nav: Home

Survey finds positive view towards living kidney donation; offering payment may motivate

March 23, 2016

In a study published online by JAMA Surgery, Thomas G. Peters, M.D., of the University of Florida College of Medicine, Jacksonville, and colleagues examined the willingness of voting U.S. citizens to become living kidney donors and to determine the potential influence of compensation for donation.

Thousands of patients with end-stage renal disease in the United States have suffered preventable deaths due to the shortage of transplantable kidneys. From 2004 to 2013, more than 63,000 persons died or became too sick for transplantation while awaiting a kidney. Currently, the U.S. kidney transplantation waiting list exceeds 100,000 patients. The severe shortage might be alleviated by compensating living kidney donors, according to background information in the study.

A survey was administered by an international polling firm in June 2014. Information was collected on willingness to donate a kidney and the potential influence of compensation ($50,000). The survey was performed via a random-digit dialing process that selected respondents via both landlines and mobile telephones to improve population representation. The survey included 1,011 registered U.S. voters likely to vote.

Of these respondents, 427 were male and 584 were female, with 43 percent of participants between ages 45 and 64 years. With respondents grouped by willingness to donate, the researchers found that 689 (68 percent) would donate a kidney to anyone and 235 (23 percent) only to certain persons; 87 (9 percent) would not donate. Most (59 percent) indicated that payment of $50,000 would make them even more likely to donate a kidney, 32 percent were unmoved by compensation. and 9 percent were negatively influenced by payment.

"Because too many U.S. patients are dying owing to the inadequate kidney supply, and because paying living kidney donors could increase the number of kidneys, we conclude that this option must be seriously considered. Amending existing federal law so that pilot studies concerning donor compensation can go forward is a reasonable start, and our findings show that it should be politically feasible. Results of such clinical trials should be the basis of regulatory policy. If pilot studies support paying living kidney donors, perhaps one day there might be a long waiting list of persons wanting to donate rather than a list of Americans waiting for kidneys that never come," the authors write.

(JAMA Surgery. Published online March 23, 2016. doi:10.1001/jamasurg.2016.0065. This study is available pre-embargo to the media at

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: An accompanying commentary, "The Ethical Dilemma of Compensating Living Kidney Donors - Alignment Between Science, Legislation, and Ethical Perception in Society?" by Marco Del Chiaro, M.D., Ph.D., of Karolinska University Hospital, Stockholm, Sweden, and colleagues is available pre-embargo at the For The Media website.

Media Advisory: To contact Thomas G. Peters, M.D., call Dan Leveton at 904-244-3268 or email

The JAMA Network Journals

Related Kidneys Articles:

Kidneys from diabetic donors may benefit many transplant candidates
Patients who received kidney transplants from donors with diabetes had better survival compared with those who remained on the waitlist.
Discovery may help prevent tissue scarring and rejection of transplanted kidneys
During rejection of a transplanted kidney, certain immune cells transform into connective tissue cells, which produce collagen and other fibers.
Diabetes study finds that cutting nerves to the kidneys improves insulin resistance
Incapacitating specific nerves to the kidneys improves the work of insulin on another organ, the liver, according to research from Cedars-Sinai recently published in the journal Diabetes.
Mount Sinai researchers identify way to predict and prevent damage in donated kidneys
A multicenter team of researchers led by Barbara Murphy, MD, of the Icahn School of Medicine at Mount Sinai has identified a panel of genes which can help predict whether a transplanted kidney will later develop fibrosis, an injury which can cause the organ to fail.
Scientists work to protect the kidneys from powerful cancer drug
Cisplatin is a common, powerful chemotherapy agent used for a wide range of cancers such as breast, ovarian and lung, that in a handful of days can also permanently damage or destroy patients' kidneys.
Donor kidneys may be discarded due to 'weekend effect' at hospitals
Investigators have uncovered a 'weekend effect' contributing to the worsening availability of donor kidneys in the United States, according to a new report in Kidney International.
Kidneys have an innate clock that affects many metabolic processes in the body
Daily fluctuations caused by the kidney's circadian clock have an important effect on the levels of various amino acids, lipids, and other components of blood in the body.
Factors associated with good heart health may also protect kidneys
Middle-aged adults who scored well on the American Heart Association's Life's Simple 7 checklist were less likely to develop chronic kidney disease than those with low scores.
Vessel discovery a major step toward growing kidneys
Researchers have identified the cells that give rise to the blood vessels within the kidney.
Newer cancer drug may help protect kidneys from damage caused by older drug
A class of drugs used increasingly to help fight cancer may have the additional benefit of protecting the kidneys when packaged with the powerful chemotherapy agent cisplatin.

Related Kidneys Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".